SCHEMBL1090612

SCHEMBL1090612

Cc1cccc(S(=O)(=O)N2CCC(N3CCCC(Nc4nccc(N5CCCCCC5)n4)C3)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.46
▸ CXCR4 P61073 1/20 0.45
▸ HPGD P15428 1/20 0.43
▸ HRH4 Q9H3N8 3/20 0.43
▸ MBTD1 Q05BQ5 1/20 0.43
▸ L3MBTL3 Q96JM7 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ GAA P10253 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ MAPK8 P45983 1/20 0.41
▸ MAPK9 P45984 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.39
▸ KDM2B Q8NHM5 1/20 0.39
▸ EBP Q15125 1/20 0.38
▸ DHCR7 Q9UBM7 1/20 0.38
▸ ALK Q9UM73 2/20 0.38
▸ IGF1R P08069 1/20 0.38
▸ SYK P43405 1/20 0.38
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089174 0.98 EPHX2 (0.48) EPHX2CXCR4HPGDHRH4MBTD1
SCHEMBL1090796 0.96 CXCR4 (0.47) EPHX2CXCR4HPGDHRH4MBTD1
SCHEMBL1090551 0.93 HRH4 (0.44) EPHX2CXCR4HRH4MAPK1MAPK8
SCHEMBL1091383 0.92 HRH4 (0.46) EPHX2CXCR4HRH4MAPK1MAPK8
SCHEMBL1089014 0.90 ALDH1A1 (0.55) EPHX2CXCR4HRH4KDM4EALDH1A1
SCHEMBL1090389 0.90 KDM4E (0.54) EPHX2CXCR4HPGDHRH4MBTD1
SCHEMBL1090317 0.89 CXCR4 (0.46) EPHX2CXCR4HRH4MAPK1MAPK8
SCHEMBL1090079 0.88 ALDH1A1 (0.55) EPHX2CXCR4HRH4KDM4EALDH1A1
SCHEMBL1089744 0.88 GAA (0.54) EPHX2CXCR4HPGDHRH4MBTD1
SCHEMBL1090671 0.88 KDM4E (0.48) CXCR4HRH4KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 — — US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 — — US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 — — US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 — — US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 EPHX2 494/4885CXCR4 1/4885HPGD 34/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 EPHX2 494/4885CXCR4 1/4885HPGD 34/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 EPHX2 494/4885CXCR4 1/4885HPGD 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback